Eosinophilia in Hematologic Disorders
- 1 August 2015
- journal article
- review article
- Published by Elsevier in Immunology and Allergy Clinics of North America
- Vol. 35 (3) , 439-452
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Pathogenesis and classification of eosinophil disorders: a review of recent developments in the fieldExpert Review of Hematology, 2012
- The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)Haematologica, 2011
- Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tractJournal of Allergy and Clinical Immunology, 2010
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Alemtuzumab Therapy for Hypereosinophilic Syndrome and Chronic Eosinophilic LeukemiaClinical Cancer Research, 2008
- Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosingBlood, 2007
- Non‐small‐cell lung cancer associated with excessive eosinophilia and secretion of interleukin‐5 as a paraneoplastic syndromeAmerican Journal of Hematology, 2006
- Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid LeukemiaNew England Journal of Medicine, 2006
- Allogeneic bone marrow transplantation for hypereosinophilic syndrome: long-term follow-up with eradication of FIP1L1-PDGFRA fusion transcriptBone Marrow Transplantation, 2006
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999